Skip to main content

About me

Pharmacist, PhD, Assistant Professor

Division of audiology

Department of clinical science, intervention, and technology (CLINTEC)

Karolinska Institutet

Alfred Nobels Allé 10, level 5

141 83 Huddinge

Telephone mobile: 072–7101935


Cooperations outside the Division of audiology

Filip Asp, PhD, MSci in Engineering, Karolinska university hospital, Stockholm.

Cecilia Engmér Berglin, PhD, ENT specialist, Karolinska university hospital, Stockholm.

Anders Fridberger, professor in neuroscience, Department of clinical and experimental medicine, Cell biology, Linköping university, Linköping.

Signe Friesland, PhD, senior consultant in oncology, Karolinska university hospital, Stockholm.

Christina Forshell Hederstierna, PhD, senior consultant in audiology, Karolinska University Hospital, Stockholm.

Mikael Hedeland, professor in analytical pharmaceutical chemistry, Uppsala University, Uppsala.

Göran Laurell, professor in ear, nose, and throat, Uppsala University, senior consultant, Uppsala university hospital, Uppsala.

Curt Pettersson, professor emeritus in analytical pharmaceutical chemistry, Department of pharmacy, Uppsala University, Uppsala.

Ulf Rosenhall, professor emeritus in clinical audiology, senior consultant, Hearing and balance clinic, Karolinska university hospital, Stockholm.

Henrik Smeds, PhD, senior consultant in ENT, Karolinska university hospital.


Publications by Pernilla Videhult Pierre

  • Fransson AE, Kisiel M, Pirttila K, Pettersson C, Videhult Pierre P, Laurell GFE (2017) Hydrogen Inhalation Protects against Ototoxicity Induced by Intravenous Cisplatin in the Guinea Pig. Front Cell Neurosci 11, 280.

  • Videhult Pierre P, Haglof J, Linder B, Engskog MKR, Arvidsson T, Pettersson C, Fransson A, Laurell G (2017) Cisplatin-Induced Metabolome Changes in Serum: An Experimental Approach to Identify Markers for Ototoxicity. Acta oto-laryngol 137, 1024-30.

  • Videhult Pierre P, Johnson A-C, Fridberger A (2015) Subjective and clinically assessed hearing loss; a cross-sectional register-based study on a Swedish population aged 18 through 50 years. PLoS One 10, e0123290.

  • Engmer Berglin C, Videhult Pierre P, Ekborn A, Bramer T, Edsman K, Hultcrantz M, Laurell G (2015) Local Treatment of the Inner Ear: A Study of Three Different Polymers Aimed for Middle Ear Administration. Acta oto-laryngol 135, 985-94.

  • Pierre PV, Fridberger A, Wikman A, Alexanderson K (2012) Self-reported hearing difficulties, main income sources, and socio-economic status; a cross-sectional population-based study in Sweden. BMC Public Health 12, 874-885.

  • Berglin CE, Pierre PV, Bramer T, Edsman K, Ehrsson H, Eksborg S, Laurell G (2011) Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model. Cancer Chemother Pharmacol 68, 1547-1556.

  • Pierre PV, Wallin I, Eksborg S, Ehrsson H (2011) Quantitative liquid chromatographic determination of intact cisplatin in blood with microwave-assisted post-column derivatization and UV detection. J Pharm Biomed Anal 56, 126-130.

  • Videhult Pierre P (2010) Doctoral thesis: Cisplatin, a platinum-containing antineoplastic drug: perspectives on analytical chemistry and prevention of ototoxicity. Karolinska Institutet, Stockholm.

  • Videhult Pierre P, Engmer C, Wallin I, Laurell G, Ehrsson H (2009) High concentrations of thiosulfate in scala tympani perilymph after systemic administration in the guinea pig. Acta Otolaryngol 129, 132-137.

  • Videhult P, Laurell G, Wallin I, Ehrsson H (2006) Degradation rate constants of cisplatin and its monohydrated complex with sulfur containing compounds designed for local ototoprotective administration. Exp Biol Med  231, 1638-45.

  • Videhult P, Yachnin J, Jerremalm R, Lewensohn R, Ehrsson H (2002) Synthesis and cytotoxicity of the dihydrated complex of oxaliplatin. Cancer Lett 180, 191-194.

  • Jerremalm E, Videhult P, Alvelius G, Griffiths WJ, Bergman T, Eksborg S, Ehrsson H (2002) Alkaline hydrolysis of oxaliplatin- isolation and identification of the oxalato monodentate intermediate. J Pharm Sci 91, 2116-2121.

Loading bibliometrics...